MFN1 and polyostotic fibrous dysplasia: miR-181a-5p combined with BMSC injection further enhanced the fibroblast differentiation of BMSCs and repaired tissue structure by down-regulating MFN1, highlighting miR-181a-5p as a new target for future PFD therapy.